American International Group’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-5,099
| Closed | -$26.7K | – | 2937 |
|
|
2024
Q1 | $26.7K | Sell |
5,099
-44
| -0.9% | -$241 | ﹤0.01% | 2898 |
|
|
2023
Q4 | $26.9K | Sell |
5,143
-21
| -0.4% | -$207 | ﹤0.01% | 2933 |
|
|
2023
Q3 | $81.4K | Buy |
5,164
+184
| +4% | +$3.31K | ﹤0.01% | 2623 |
|
|
2023
Q2 | $96.8K | Sell |
4,980
-617
| -11% | -$14.6K | ﹤0.01% | 2595 |
|
|
2023
Q1 | $159K | Buy |
5,597
+24
| +0.4% | +$712 | ﹤0.01% | 2243 |
|
|
2022
Q4 | $163K | Sell |
5,573
-127
| -2% | -$4.04K | ﹤0.01% | 2248 |
|
|
2022
Q3 | $151K | Buy |
5,700
+22
| +0.4% | +$807 | ﹤0.01% | 2320 |
|
|
2022
Q2 | $252K | Sell |
5,678
-868
| -13% | -$39.9K | ﹤0.01% | 2042 |
|
|
2022
Q1 | $324K | Sell |
6,546
-403
| -6% | -$19.3K | ﹤0.01% | 1968 |
|
|
2021
Q4 | $354K | Sell |
6,949
-335
| -5% | -$17.4K | ﹤0.01% | 2030 |
|
|
2021
Q3 | $406K | Sell |
7,284
-264
| -3% | -$13K | ﹤0.01% | 1997 |
|
|
2021
Q2 | $323 | Buy |
7,548
+533
| +8% | +$22K | ﹤0.01% | 2207 |
|
|
2021
Q1 | $293 | Sell |
7,015
-89
| -1% | -$4.13K | ﹤0.01% | 2153 |
|
|
2020
Q4 | $331 | Sell |
7,104
-535
| -7% | -$25K | ﹤0.01% | 1999 |
|
|
2020
Q3 | $325K | Buy |
7,639
+2
| +0% | +$87 | ﹤0.01% | 1831 |
|
|
2020
Q2 | $366K | Buy |
7,637
+1,277
| +20% | +$63.7K | ﹤0.01% | 1760 |
|
|
2020
Q1 | $293K | Sell |
6,360
-312
| -5% | -$15.7K | ﹤0.01% | 1695 |
|
|
2019
Q4 | $401K | Sell |
6,672
-190
| -3% | -$11.3K | ﹤0.01% | 1819 |
|
|
2019
Q3 | $388K | Sell |
6,862
-212
| -3% | -$11.9K | ﹤0.01% | 1797 |
|
|
2019
Q2 | $394K | Sell |
7,074
-878
| -11% | -$45.8K | ﹤0.01% | 1833 |
|
|
2019
Q1 | $401K | Sell |
7,952
-298
| -4% | -$13.3K | ﹤0.01% | 1840 |
|
|
2018
Q4 | $332K | Sell |
8,250
-116
| -1% | -$5.98K | ﹤0.01% | 1889 |
|
|
2018
Q3 | $580K | Buy |
8,366
+594
| +8% | +$45K | ﹤0.01% | 1796 |
|
|
2018
Q2 | $588K | Buy |
7,772
+2,633
| +51% | +$166K | ﹤0.01% | 1723 |
|
|
2018
Q1 | $271K | Sell |
5,139
-1,292
| -20% | -$75.1K | ﹤0.01% | 2088 |
|
|
2017
Q4 | $344K | Sell |
6,431
-131
| -2% | -$7.29K | ﹤0.01% | 2003 |
|
|
2017
Q3 | $391K | Buy |
6,562
+446
| +7% | +$27K | ﹤0.01% | 1902 |
|
|
2017
Q2 | $482K | Buy |
6,116
+665
| +12% | +$54.4K | ﹤0.01% | 1734 |
|
|
2017
Q1 | $452K | Sell |
5,451
-881
| -14% | -$65.5K | ﹤0.01% | 1661 |
|
|
2016
Q4 | $502K | Sell |
6,332
-104
| -2% | -$7.55K | ﹤0.01% | 1631 |
|
|
2016
Q3 | $451K | Buy |
6,436
+1,339
| +26% | +$74.2K | ﹤0.01% | 1675 |
|
|
2016
Q2 | $198K | Sell |
5,097
-528
| -9% | -$22K | ﹤0.01% | 2140 |
|
|
2016
Q1 | $228K | Hold |
5,625
| – | – | ﹤0.01% | 2664 |
|
|
2015
Q4 | $499K | Sell |
5,625
-9
| -0.2% | -$711 | ﹤0.01% | 2040 |
|
|
2015
Q3 | $417K | Buy |
5,634
+606
| +12% | +$50.4K | ﹤0.01% | 2170 |
|
|
2015
Q2 | $407K | Buy |
+5,028
| New | +$328K | ﹤0.01% | 2359 |
|
Other funds holding EGRX
NCM
ACM
American International Group's EGRX Position: Q2 2024 in Review
American International Group sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q2 2024, closing a stake of 5,099 shares — an estimated $26.7K sold.
American International Group first reported a position in EGRX in Q2 2015 and held it in 36 quarters. The position peaked at $588K in Q2 2018. 75 funds tracked by Wall St. Rank hold EGRX as of Q2 2024.
- American International Group reported no remaining Eagle Pharmaceuticals, Inc. position as of Q2 2024 after selling out during the quarter.
- American International Group sold 5,099 Eagle Pharmaceuticals, Inc. shares in Q2 2024, an estimated $26.7K.
- American International Group first reported a position in Eagle Pharmaceuticals, Inc. in Q2 2015 and held it in 36 quarters.
- American International Group's Eagle Pharmaceuticals, Inc. position peaked at $588K in Q2 2018.
- 75 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q2 2024.
Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.